Linking Mechanism of Action to Safety Profiles in mCRC TreatmentByGabriel Schwartz, MSN, NPNovember 15th 2025Gabriel Schwartz, MSN, NP, explains how mechanisms of action determine the safety of systemic treatments in metastatic colorectal cancer post chemotherapy.